Cancer Care Ontario | Action Cancer Ontario

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

16 Results

Guidelines and Advice

Follow-up for Cervical Cancer

Status: Current
ID: 4-16
Version: 3

Dec 1969

Guidelines and Advice

Follow-up After Primary Therapy for Endometrial Cancer

Status: Current
ID: 4-9
Version: 2

Dec 1969

Guidelines and Advice

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Status: Archived
ID: 6-23 (CED)

Jan 2012

Guidelines and Advice

Docetaxel plus Cyclophosphamide as Adjuvant Therapy for Early, Operable Breast Cancer

Status: Archived
ID: CED 9

Dec 1969

Guidelines and Advice

Fulvestrant for Systemic Therapy of Locally Advanced or Metastatic Breast Cancer in Postmenopausal Women: Guideline Recommendations

Status: Archived
ID: 1-13

Sep 2008

Guidelines and Advice

Dose-intensive Chemotherapy with Growth Factor or Autologous Bone Marrow/Stem Cell Transplant Support in Advanced or Metastatic Adult Soft Tissue Sarcoma

Status: Archived
ID: 11-5

Sep 2011

Guidelines and Advice

Doxorubicin-Based Chemotherapy for the Palliative Treatment of Adult Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Status: Archived
ID: 11-1
Version: 2

Oct 2014

Guidelines and Advice

Dose Objectives for Head and Neck IMRT Treatment Planning - Recommendation Report

Status: Current
ID: GL-C50-13

Dec 1969

Guidelines and Advice

Focal Tumour Ablation in Ontario: Recommendations Report 2015

Status: Current
ID: GL-C50-19

Jan 2015

Guidelines and Advice

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Status: In-Review
ID: RR SCT-9
Version: N/A

Dec 1969

Guidelines and Advice

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Status: Current
Version: 2

Sep 2025

Guidelines and Advice

First-line treatment of advanced-stage Hodgkin lymphoma

Status: Current
ID: ES 6-25

Oct 2024

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Follow-up for Cervical Cancer

Follow-up After Primary Therapy for Endometrial Cancer

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Docetaxel plus Cyclophosphamide as Adjuvant Therapy for Early, Operable Breast Cancer

Fulvestrant for Systemic Therapy of Locally Advanced or Metastatic Breast Cancer in Postmenopausal Women: Guideline Recommendations

Dose-intensive Chemotherapy with Growth Factor or Autologous Bone Marrow/Stem Cell Transplant Support in Advanced or Metastatic Adult Soft Tissue Sarcoma

Doxorubicin-Based Chemotherapy for the Palliative Treatment of Adult Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Dose Objectives for Head and Neck IMRT Treatment Planning - Recommendation Report

Focal Tumour Ablation in Ontario: Recommendations Report 2015

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

First-line treatment of advanced-stage Hodgkin lymphoma

Pages